AU2022319690A1 - Compositions And Techniques For Vaginal Insertion - Google Patents

Compositions And Techniques For Vaginal Insertion Download PDF

Info

Publication number
AU2022319690A1
AU2022319690A1 AU2022319690A AU2022319690A AU2022319690A1 AU 2022319690 A1 AU2022319690 A1 AU 2022319690A1 AU 2022319690 A AU2022319690 A AU 2022319690A AU 2022319690 A AU2022319690 A AU 2022319690A AU 2022319690 A1 AU2022319690 A1 AU 2022319690A1
Authority
AU
Australia
Prior art keywords
composition
poloxamer
active ingredient
viscosity
million
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022319690A
Other languages
English (en)
Inventor
David Friend
Jennifer KIANG
Nicolas J. Pacelli
Mark Walters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dare Bioscience Inc
Original Assignee
Dare Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dare Bioscience Inc filed Critical Dare Bioscience Inc
Publication of AU2022319690A1 publication Critical patent/AU2022319690A1/en
Assigned to DARE BIOSCIENCE, INC. reassignment DARE BIOSCIENCE, INC. Amend patent request/document other than specification (104) Assignors: DARE BIOSCIENCE, INC., FRIEND, DAVID, KIANG, Jennifer, PACELLI, NICOLAS J., WALTERS, MARK
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2022319690A 2021-07-26 2022-07-25 Compositions And Techniques For Vaginal Insertion Pending AU2022319690A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163225872P 2021-07-26 2021-07-26
US63/225,872 2021-07-26
US202163285447P 2021-12-02 2021-12-02
US63/285,447 2021-12-02
US202263331749P 2022-04-15 2022-04-15
US63/331,749 2022-04-15
PCT/US2022/038234 WO2023009461A2 (en) 2021-07-26 2022-07-25 Compositions and techniques for vaginal insertion

Publications (1)

Publication Number Publication Date
AU2022319690A1 true AU2022319690A1 (en) 2024-03-14

Family

ID=82899311

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022319690A Pending AU2022319690A1 (en) 2021-07-26 2022-07-25 Compositions And Techniques For Vaginal Insertion

Country Status (5)

Country Link
US (1) US20240189265A1 (https=)
EP (1) EP4376890A2 (https=)
JP (1) JP2024529479A (https=)
AU (1) AU2022319690A1 (https=)
WO (1) WO2023009461A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024155777A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155775A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024158951A2 (en) * 2023-01-25 2024-08-02 Dare Bioscience, Inc. Compositions and methods for treating dysmenorrhea
WO2025212773A1 (en) * 2024-04-03 2025-10-09 Daré Bioscience, Inc. Lactobacillus gel formulation and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825234B2 (en) * 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
EP2010133B1 (en) * 2006-03-31 2016-05-04 Stiefel Research Australia Pty Ltd Foamable suspension gel
EA030035B1 (ru) * 2007-11-06 2018-06-29 Меламед, Лемуил Применение s-этилизотиоурония диэтилфосфата для изготовления лекарственного средства для лечения нарушения матки
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
EP2520279A1 (en) * 2011-05-02 2012-11-07 TERES S.r.l. Thermoreversible gel pharamaceutical compositions for odontoiatric use
WO2014042604A1 (en) * 2012-09-11 2014-03-20 Imuneks Farma Mac Sanayi Ve Ticaret A.S. Clindamycin phosphate, salicylic acid and tea tree oil combinations
AU2013362794B2 (en) * 2012-12-20 2018-02-22 Smilesonica Inc. Internal ultrasound gel
WO2017015232A1 (en) * 2015-07-20 2017-01-26 Trilogic Pharma Llc Topical formulations and treatments
BR112021008100A2 (pt) * 2018-11-05 2021-08-03 Inspired Material Solutions, LLC carreador e protetor de pele dérmico

Also Published As

Publication number Publication date
WO2023009461A2 (en) 2023-02-02
US20240189265A1 (en) 2024-06-13
EP4376890A2 (en) 2024-06-05
JP2024529479A (ja) 2024-08-06
WO2023009461A3 (en) 2023-07-13

Similar Documents

Publication Publication Date Title
US20240189265A1 (en) Compositions and techniques for vaginal insertion
JP6864001B2 (ja) ゾル−ゲルポリマー組成物及びそれらの使用
KR101792200B1 (ko) 열감응성 겔 마취제 조성물
CN100488517C (zh) 捕获和灭活病原性微生物和精子的组合物及其制药用途
JP7123971B2 (ja) 乳腺炎を処置する際に使用する動物用組成物、及び関連方法
RO109156B1 (ro) Compozitie cu metronidazol,pentru infectiile vaginale si metoda de tratament cu aceasta
Abd Ellah et al. Dual-responsive lidocaine in situ gel reduces pain of intrauterine device insertion
JP2013100364A (ja) ヒトの分娩を容易にするための新規組成物
ES2891754T3 (es) Formulaciones y tratamientos tópicos
US20240165141A1 (en) Systems and methods for treatment of bacterial vaginosis
US20200376002A1 (en) Injectable Hormone Formulations for Estrous Cycle Control in Mammals, its Manufacturing Process, Estrous Cycle Control and Puberty Triggering Methods, and Pregnancy Enhancement in Mammals
CN101500583B (zh) 含克林霉素盐酸盐的药物递送聚合物
JP7454288B2 (ja) 新規な獣用子宮注入剤の調製方法
AU2018390990A1 (en) Treatment of pain and/or pain related symptoms associated with dysmenorrhea
Jensen et al. Characterization of tubal occlusion after transcervical polidocanol foam (PF) infusion in baboons
CA3227295A1 (en) Compositions and techniques for vaginal insertion
TWI429427B (zh) 輸送系統
De Cramer Surgical uterine drainage and lavage as treatment for canine pyometra: clinical communication
CN118317794A (zh) 用于治疗痛经的组合物
CN1929815B (zh) 用于阴道治疗的含磷酸甘露糖组合物
WO2024158951A2 (en) Compositions and methods for treating dysmenorrhea
WO2024155777A2 (en) Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155775A2 (en) Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
ES2983432T3 (es) Composición para el tratamiento y/o la prevención de la vestibulodinia
Khasraghi Formulation and In Vitro Evaluation of Mucoadhesive Nystatin Vaginal Gel

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: DARE BIOSCIENCE, INC.

Free format text: FORMER NAME(S): DARE BIOSCIENCE, INC.; WALTERS, MARK; PACELLI, NICOLAS J.; KIANG, JENNIFER; FRIEND, DAVID

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ COMPOSITIONS AND TECHNIQUES FOR VAGINAL INSERTION